FDA Approves First Treatment for Geographic Atrophy
Pegcetacoplan approved as an injection with dosing every 25 to 60 days
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Pegcetacoplan approved as an injection with dosing every 25 to 60 days
Only registered members have full access to PracticeUpdate content.